NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

BSX

Boston Scientific Corp

Jul 01 • 04:00PM ET

104.78

Dollar change -2.63
Percentage change -2.45	%

Healthcare • Medical Devices • USA • NYSE

Peers: MDT ABT JNJ SYK ZBH ISRG BDX EW HOLX XRAY

| Held by: VTI VOO SPY IVV VUG XLV IHI VHT IVW IWD

Scroll to Statements

Index	S&P 500	P/E	76.77	EPS (ttm)	1.36	Insider Own	0.40%	Shs Outstand	1.48B	Perf Week	0.63%
Market Cap	155.02B	Forward P/E	31.71	EPS next Y	3.30	Insider Trans	-12.18%	Shs Float	1.47B	Perf Month	-0.46%
Enterprise Value	166.13B	PEG	5.46	EPS next Q	0.72	Inst Own	92.17%	Short Float	1.19%	Perf Quarter	3.87%
Income	2.03B	P/S	8.83	EPS this Y	16.31%	Inst Trans	0.54%	Short Ratio	2.10	Perf Half Y	14.58%
Sales	17.55B	P/B	6.98	EPS next Y	13.19%	ROA	5.29%	Short Interest	17.49M	Perf YTD	17.31%
Book/sh	15.02	P/C	187.22	EPS next 5Y	14.06%	ROE	9.65%	52W High	107.53 -2.56%	Perf Year	36.08%
Cash/sh	0.56	P/FCF	51.43	EPS past 3/5Y	21.99% -17.84%	ROIC	6.13%	52W Low	71.88 45.77%	Perf 3Y	175.59%
Dividend Est.	-	EV/EBITDA	39.58	Sales past 3/5Y	12.10% 9.30%	Gross Margin	61.84%	Volatility	1.55% 1.74%	Perf 5Y	209.54%
Dividend TTM	-	EV/Sales	9.46	EPS Y/Y TTM	14.31%	Oper. Margin	16.56%	ATR (14)	1.93	Perf 10Y	483.73%
Dividend Ex-Date	-	Quick Ratio	0.88	Sales Y/Y TTM	19.35%	Profit Margin	11.58%	RSI (14)	56.17	Recom	1.34
Dividend Gr. 3/5Y	- -	Current Ratio	1.45	EPS Q/Q	35.11%	SMA20	2.35%	Beta	0.68	Target Price	120.69
Payout	0.00%	Debt/Eq	0.53	Sales Q/Q	20.93%	SMA50	1.84%	Rel Volume	1.02	Prev Close	107.41
Employees	53000	LT Debt/Eq	0.49	Earnings	Apr 23 BMO	SMA200	9.50%	Avg Volume	8.35M	Price	104.78
IPO	May 19, 1992	Option/Short	Yes / Yes	EPS/Sales Surpr.	11.46% 2.00%	Trades		Volume	8,521,559	Change	-2.45%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-16-25	Initiated	Leerink Partners	Outperform	$118
Apr-16-25	Upgrade	Needham	Hold → Buy	$113
Jan-10-25	Upgrade	Deutsche Bank	Hold → Buy	$108
Oct-18-24	Downgrade	Needham	Buy → Hold
May-30-24	Initiated	Goldman	Buy	$90
Feb-01-24	Upgrade	Mizuho	Neutral → Buy	$65 → $80
Jul-19-23	Initiated	Robert W. Baird	Outperform	$59
Jun-30-23	Initiated	CL King	Buy	$64
May-30-23	Resumed	Morgan Stanley	Overweight	$58
Mar-29-23	Initiated	UBS	Buy	$57
Dec-22-22	Initiated	Mizuho	Neutral	$52
Dec-20-22	Resumed	Citigroup	Buy	$54
Oct-18-22	Initiated	Barclays	Overweight	$49
Oct-12-22	Initiated	Jefferies	Buy	$50
Jul-06-22	Initiated	Wolfe Research	Outperform	$43
May-27-22	Upgrade	Needham	Hold → Buy	$48
Apr-13-22	Resumed	Truist	Buy	$52
Mar-02-22	Resumed	BofA Securities	Buy	$55
Dec-10-21	Initiated	RBC Capital Mkts	Outperform	$51
May-26-21	Downgrade	Needham	Buy → Hold

Show Previous Ratings

Today 09:14AM	Boston Scientific Climbs 40.5% in a Year: What's Driving the Stock? (Zacks)
08:00AM	Boston Scientific announces conference call discussing second quarter 2025 results (PR Newswire)
Jun-30-25 02:22PM	Wall Street Analysts Have Given the Most Buy Ratings Since 2022. It's a Sign. (Barrons.com)
11:40AM	PAHC vs. BSX: Which Stock Is the Better Value Option? (Zacks)
08:49AM	Bio-Techne's New USP Deal on mAb and Gene Therapy May Boost Its Stock (Zacks)
08:10PM	Loading…
Jun-27-25 08:10PM	Analyst Report: Boston Scientific Corporation (Morningstar Research)
06:00PM	Boston Scientific (BSX) Surpasses Market Returns: Some Facts Worth Knowing (Zacks)
09:16AM	Do You Believe in the Growth Trajectory of Boston Scientific Corporation (BSX)? (Insider Monkey)
Jun-26-25 09:40AM	J&J's MedTech Segment Slowing Down: Will its Sales Recover in 2025? (Zacks)
09:16AM	BSX vs. MDT: Which MedSurg Stock Is the Better Investment Now? (Zacks)
Jun-25-25 08:50AM	Want Better Returns? Don?t Ignore These 2 Medical Stocks Set to Beat Earnings (Zacks)
Jun-24-25 02:07PM	Teladoc (TDOC) Moves 14.4% Higher: Will This Strength Last? (Zacks)
10:42AM	Exelixis (EXEL) Surges 7.4%: Is This an Indication of Further Gains? (Zacks)
10:40AM	Strength Seen in Nektar (NKTR): Can Its 12.1% Jump Turn into More Strength? (Zacks)
09:40AM	Are Business Services Stocks Lagging GORILLA TECH GP (GRRR) This Year? (Zacks)
09:40AM	Loading…
09:40AM	Is Air Lease (AL) Stock Outpacing Its Transportation Peers This Year? (Zacks)
09:40AM	Are Utilities Stocks Lagging Entergy (ETR) This Year? (Zacks)
09:40AM	Is GRINDR INC (GRND) Stock Outpacing Its Computer and Technology Peers This Year? (Zacks)
09:40AM	Is Axos Financial (AX) Stock Outpacing Its Finance Peers This Year? (Zacks)
09:40AM	Are Aerospace Stocks Lagging CurtissWright (CW) This Year? (Zacks)
09:40AM	Is DXP Enterprises (DXPE) Outperforming Other Industrial Products Stocks This Year? (Zacks)
09:40AM	Is Douglas Dynamics (PLOW) Outperforming Other Auto-Tires-Trucks Stocks This Year? (Zacks)
09:40AM	Are Consumer Discretionary Stocks Lagging Atour Lifestyle Holdings Limited Sponsored ADR (ATAT) This Year? (Zacks)
09:40AM	Are Basic Materials Stocks Lagging CF Industries (CF) This Year? (Zacks)
09:40AM	Is The Ensign Group (ENSG) Stock Outpacing Its Medical Peers This Year? (Zacks)
09:30AM	Brokers Suggest Investing in Boston Scientific (BSX): Read This Before Placing a Bet (Zacks)
08:54AM	Strength Seen in Brainsway (BWAY): Can Its 5.3% Jump Turn into More Strength? (Zacks)
08:50AM	Why Investors Need to Take Advantage of These 2 Medical Stocks Now (Zacks)
08:27AM	BSX Raises 2025 Financial Outlook: What's Backing It? (Zacks)
07:56AM	RGC Resources (RGCO) Surges 9.1%: Is This an Indication of Further Gains? (Zacks)
04:41AM	Loading…
04:41AM	Strength Seen in Mobileye (MBLY): Can Its 11.6% Jump Turn into More Strength? (Zacks)
Jun-23-25 06:15PM	Boston Scientific (BSX) Surpasses Market Returns: Some Facts Worth Knowing (Zacks)
Jun-20-25 09:45AM	Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio (Zacks)
05:01AM	24-Acre Minnetonka Complex Put Up for Sale by Boston Scientific (BSX) (Insider Monkey)
Jun-18-25 09:12AM	BSX's Neuromodulation Arm Sees Growth: Q1 Highlights (Zacks)
08:55AM	ISRG vs BSX: Which Medical Device Stock Has More Room to Run? (Zacks)
06:26AM	Boston Scientific's Q1 Earnings Call: Our Top 5 Analyst Questions (StockStory)
Jun-17-25 09:35AM	Cisco upgraded, CoreWeave downgraded: Wall Streets top analyst calls (TipRanks)
06:20AM	Should You Invest in the iShares U.S. Medical Devices ETF (IHI)? (Zacks)
Jun-16-25 09:54AM	Leerink starts coverage on Boston Scientific and Medtronic with bullish ratings (Investing.com)
Jun-13-25 06:00PM	Why the Market Dipped But Boston Scientific (BSX) Gained Today (Zacks)
11:40AM	ATGE or UTI: Which Is the Better Value Stock Right Now? (Zacks)
11:40AM	AL vs. WAB: Which Stock Is the Better Value Option? (Zacks)
11:40AM	PAHC vs. BSX: Which Stock Should Value Investors Buy Now? (Zacks)
11:40AM	ODP or ULTA: Which Is the Better Value Stock Right Now? (Zacks)
11:40AM	NEXA or WPM: Which Is the Better Value Stock Right Now? (Zacks)
08:19AM	BSX Q1 Endoscopy Sales Rise 6%: What's Behind the Growth? (Zacks)
Jun-10-25 08:08PM	Analyst Report: Boston Scientific Corporation (Morningstar Research)
10:53AM	20 stocks bucking bad trends on Wall Street - what might be next for them? (MarketWatch)
08:53AM	Cardiovascular Tailwind Boosts BSX: Here's How to Play the Stock (Zacks)
Jun-06-25 04:08PM	Healthcare companies are hiring. Is it time to look for growth stocks in this beaten-down sector? (MarketWatch)
02:42PM	3 Growth Stocks That Aren't the Magnificent 7 (Barrons.com)
12:00PM	Boston Scientific (BSX) Upgraded to Buy: Here's Why (Zacks)
09:40AM	Is Boston Scientific (BSX) Stock Outpacing Its Medical Peers This Year? (Zacks)
09:30AM	Wall Street Bulls Look Optimistic About Boston Scientific (BSX): Should You Buy? (Zacks)
Jun-04-25 06:00PM	Boston Scientific (BSX) Stock Declines While Market Improves: Some Information for Investors (Zacks)
10:31AM	Profit From the Silver Tsunami: Must-Watch Senior Care & Aging Stocks (Zacks)
09:45AM	Here's Why Boston Scientific (BSX) is a Strong Growth Stock (Zacks)
09:04AM	Emerging Markets Power Boston Scientific: Will the Growth Trend Continue? (Zacks)
Jun-02-25 03:18PM	Solventum Stock Earns RS Rating Upgrade (Investor's Business Daily)
May-30-25 11:31AM	Why Is SurModics (SRDX) Up 6% Since Last Earnings Report? (Zacks)
May-29-25 06:00PM	Boston Scientific (BSX) Stock Declines While Market Improves: Some Information for Investors (Zacks)
07:00AM	Michael Mahoney Turned Boston Scientific Into A Medical Tech Empire (Investor's Business Daily)
02:41AM	Boston Scientific plans changes to expected $200M tariff hit as situation shifts (MedTech Dive)
May-28-25 11:40AM	PAHC or BSX: Which Is the Better Value Stock Right Now? (Zacks)
10:17AM	How Boston Scientific's Surprise Setback Bolstered Edwards, Medtronic, Abbott (Investor's Business Daily)
10:14AM	How Boston Scientific's Surprise Setback Bolstered Two Of Its Top Rivals (Investor's Business Daily)
10:08AM	Boston Scientific ends TAVR sales; J&J shares Monarch robot data (MedTech Dive)
May-25-25 11:31PM	Boston Scientific (NYSE:BSX) Q1 Earnings: Leading The Medical Devices & Supplies - Diversified Pack (StockStory)
May-23-25 11:30AM	Boston Scientific (BSX) Up 3.3% Since Last Earnings Report: Can It Continue? (Zacks)
06:29AM	Was Jim Cramer Right About Boston Scientific Corporation (BSX)? (Insider Monkey)
May-22-25 11:58AM	Stryker wins FDA clearance for minimally invasive back pain treatment (MedTech Dive)
May-21-25 08:30AM	Here's How Much You'd Have If You Invested $1000 in Boston Scientific a Decade Ago (Zacks)
May-19-25 09:13AM	ZBH Stock to Gain From Buyouts and Innovations Amid Macro Issues (Zacks)
09:08AM	Intravascular lithotripsy: market competition and clinical potential (Medical Device Network)
07:47AM	Abbott Reveals Positive Outcome From REFLECT Studies, Stock Climbs (Zacks)
May-16-25 07:06PM	Analyst Report: Boston Scientific Corporation (Morningstar Research)
07:47AM	Should You Continue to Hold Medtronic Stock in Your Portfolio Now? (Zacks)
May-15-25 10:51AM	GE HealthCare Stock May Gain as FDA Approves Optison for Pediatric Use (Zacks)
10:08AM	Here's Why You Should Hold Accuray Stock in Your Portfolio for Now (Zacks)
May-14-25 08:49AM	Alcon Q1 Earnings Miss Estimates, Stock Down, 2025 EPS View Lowered (Zacks)
07:11AM	Is it Worth Retaining Boston Scientific Stock in Your Portfolio Now? (Zacks)
May-13-25 12:15PM	DaVita Stock Down Despite Q1 Earnings Beat, Margins Contract (Zacks)
09:41AM	Prestige Consumer Stock Up 8% Since Q4 Earnings Beat, Margin Increase (Zacks)
09:26AM	GEHC Stock Surges as SIGNA Sprint MRI Redefines 1.5T Imaging Tech (Zacks)
07:48AM	Should You Continue to Retain DGX Stock in Your Portfolio? (Zacks)
May-12-25 01:04PM	PACB Stock May Rise Following the Deal With Chulalongkorn University (Zacks)
11:40AM	PAHC or BSX: Which Is the Better Value Stock Right Now? (Zacks)
09:40AM	Are Medical Stocks Lagging Bayer (BAYRY) This Year? (Zacks)
09:10AM	Insulet Q1 Earnings Top Estimates, Stock Up, 2025 Sales View Raised (Zacks)
08:40AM	HAE Stock Gains on Q4 Earnings and Revenue Beat, Margins Up (Zacks)
07:24AM	GMED Q1 Earnings & Revenues Miss, '25 EPS View Down, Stock Falls (Zacks)
May-09-25 01:29PM	Veracyte Stock Gains on Q1 Earnings and Revenue Beat, Gross Margin Up (Zacks)
12:03PM	TMDX Stock Gains Post Q1 Earnings & Revenue Beat, Gross Margin Down (Zacks)
12:01PM	AMN Stock Gains Following Q1 Earnings & Revenue Beat, Margins Down (Zacks)
12:00PM	PacBio Stock Down Despite Q1 Earnings & Revenue Beat Estimates (Zacks)
10:20AM	What Makes Boston Scientific Corporation (BSX) A Compelling Name Within The Large-Cap Medical Device Space? (Insider Monkey)
08:49AM	Illumina Q1 Earnings Top Estimates, Revenues Down Y/Y, Stock Dips (Zacks)
07:49AM	Why Boston Scientific Corporation (BSX) Is Among the Best Medical Device Stocks to Buy Now (Insider Monkey)
03:48AM	Elutia Inc (ELUT) Q1 2025 Earnings Call Highlights: Strategic Growth and Challenges in Transition (GuruFocus.com)

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
JOSEPH M FITZGERALD	Officer	Jul 01 '25	Proposed Sale	106.97	50,000	5,348,310		Jul 01 04:09 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Jun 04 '25	Option Exercise	26.15	56,372	1,474,128	234,714	Jun 04 07:44 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Jun 04 '25	Sale	102.88	56,372	5,799,630	178,342	Jun 04 07:44 PM
JOSEPH M FITZGERALD	Officer	Jun 04 '25	Proposed Sale	102.88	56,372	5,799,625		Jun 04 04:02 PM
Mahoney Michael F	Chairman, President & CEO	Jun 02 '25	Option Exercise	20.67	105,619	2,183,161	1,641,325	Jun 03 04:47 PM
Mahoney Michael F	Chairman, President & CEO	Jun 02 '25	Sale	103.69	164,443	17,051,136	1,476,882	Jun 03 04:47 PM
MICHAEL F MAHONEY	Officer	Jun 02 '25	Proposed Sale	103.69	164,443	17,051,132		Jun 02 04:05 PM
LUDWIG EDWARD J	Director	May 29 '25	Sale	104.59	4,000	418,368	22,479	May 30 04:08 PM
LUDWIG EDWARD J	Director	May 29 '25	Proposed Sale	104.54	4,000	418,160		May 29 03:39 PM
Brown Vance R	SVP, GC and Corp. Secretary	May 21 '25	Sale	106.42	4,826	513,583	31,367	May 22 04:08 PM
VANCE BROWN	Officer	May 21 '25	Proposed Sale	106.42	4,826	513,583		May 21 04:09 PM
Sorenson John Bradley	EVP, Global Operations	May 02 '25	Option Exercise	0.00	4,204	0	25,195	May 06 04:37 PM
Sorenson John Bradley	EVP, Global Operations	May 05 '25	Sale	104.54	4,572	477,957	18,705	May 06 04:37 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	May 02 '25	Option Exercise	0.00	2,102	0	24,337	May 06 04:36 PM
Mahoney Michael F	Chairman, President & CEO	May 01 '25	Option Exercise	20.67	105,619	2,183,161	1,700,149	May 05 05:16 PM
Mahoney Michael F	Chairman, President & CEO	May 01 '25	Sale	102.48	164,443	16,851,974	1,535,706	May 05 05:16 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	May 01 '25	Option Exercise	24.81	17,314	429,515	39,549	May 05 05:16 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	May 01 '25	Sale	102.06	17,314	1,766,982	22,235	May 05 05:16 PM
JOHN B SORENSON	Officer	May 05 '25	Proposed Sale	104.54	4,572	477,957		May 05 04:04 PM
MICHAEL F MAHONEY	Officer	May 01 '25	Proposed Sale	102.48	164,443	16,851,966		May 01 04:05 PM
ARTHUR C BUTCHER	Officer	May 01 '25	Proposed Sale	102.06	17,314	1,766,981		May 01 04:01 PM
Brown Vance R	SVP, GC and Corp. Secretary	Apr 21 '25	Sale	95.09	4,826	458,904	36,193	Apr 22 04:09 PM
VANCE BROWN	Officer	Apr 21 '25	Proposed Sale	95.09	4,826	458,904		Apr 21 04:01 PM
Mahoney Michael F	Chairman, President & CEO	Apr 01 '25	Option Exercise	20.67	105,618	2,183,144	1,758,972	Apr 02 04:12 PM
Mahoney Michael F	Chairman, President & CEO	Apr 01 '25	Sale	100.01	164,442	16,445,072	1,594,530	Apr 02 04:12 PM
MICHAEL F MAHONEY	Officer	Apr 01 '25	Proposed Sale	100.01	164,442	16,445,068		Apr 01 04:11 PM
Brown Vance R	SVP, GC and Corp. Secretary	Mar 21 '25	Sale	100.85	4,826	486,702	41,019	Mar 24 04:26 PM
VANCE BROWN	Officer	Mar 21 '25	Proposed Sale	100.85	4,826	486,702		Mar 21 04:01 PM
Woodworth Emily	SVP, Global Controller and CAO	Mar 03 '25	Option Exercise	37.50	5,949	223,088	8,063	Mar 05 04:16 PM
Woodworth Emily	SVP, Global Controller and CAO	Mar 03 '25	Sale	104.97	7,149	750,465	914	Mar 05 04:16 PM
Woodworth Emily	SVP, Global Controller and CAO	Mar 04 '25	Sale	104.63	482	50,432	432	Mar 05 04:16 PM
Woodworth Emily	SVP, Global Controller and CAO	Feb 28 '25	Option Exercise	42.16	7,218	304,311	11,519	Mar 03 04:11 PM
Woodworth Emily	SVP, Global Controller and CAO	Mar 01 '25	Option Exercise	0.00	837	0	2,469	Mar 03 04:11 PM
Woodworth Emily	SVP, Global Controller and CAO	Feb 28 '25	Sale	101.13	9,887	999,872	1,632	Mar 03 04:11 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 24 '25	Sale	104.25	4,675	487,369	28,454	Feb 25 04:41 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 25 '25	Sale	104.00	2,688	279,552	25,766	Feb 25 04:41 PM
JEFFREY B MIRVISS	Officer	Feb 25 '25	Proposed Sale	104.00	2,688	279,552		Feb 25 04:02 PM
Zane Ellen M	Director	Feb 24 '25	Sale	104.23	13,586	1,416,134	34,944	Feb 24 04:08 PM
JEFFREY B MIRVISS	Officer	Feb 24 '25	Proposed Sale	104.25	4,675	487,369		Feb 24 04:01 PM
Zane Ellen M	Director	Feb 24 '25	Proposed Sale	104.23	13,586	1,416,088		Feb 24 11:30 AM
Brown Vance R	SVP, GC and Corp. Secretary	Feb 21 '25	Sale	104.64	4,826	504,993	45,845	Feb 21 04:15 PM
VANCE BROWN	Officer	Feb 21 '25	Proposed Sale	104.64	4,826	504,993		Feb 21 04:03 PM
Sorenson John Bradley	EVP, Global Operations	Feb 19 '25	Sale	105.19	3,303	347,443	20,991	Feb 19 04:23 PM
Sorenson John Bradley	EVP, Global Operations	Feb 18 '25	Sale	104.41	2,657	277,417	24,294	Feb 19 04:23 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 19 '25	Sale	105.35	1,510	159,078	33,129	Feb 19 04:23 PM
Brennan Daniel J.	EVP and CFO	Feb 19 '25	Option Exercise	25.61	60,523	1,550,275	293,141	Feb 19 04:23 PM
Brennan Daniel J.	EVP and CFO	Feb 19 '25	Sale	105.24	67,333	7,086,111	225,808	Feb 19 04:23 PM
Brennan Daniel J.	EVP and CFO	Feb 18 '25	Sale	104.57	17,530	1,833,184	232,618	Feb 19 04:23 PM
DANIEL BRENNAN	Officer	Feb 19 '25	Proposed Sale	105.24	67,333	7,086,109		Feb 19 04:05 PM
JEFFREY B MIRVISS	Officer	Feb 19 '25	Proposed Sale	105.35	1,510	159,078		Feb 19 04:01 PM
JOHN B SORENSON	Officer	Feb 19 '25	Proposed Sale	105.19	3,303	347,443		Feb 19 04:01 PM
Woodworth Emily	SVP, Global Controller and CAO	Feb 14 '25	Option Exercise	0.00	661	0	3,867	Feb 18 05:53 PM
Woodworth Emily	SVP, Global Controller and CAO	Feb 16 '25	Option Exercise	0.00	636	0	4,188	Feb 18 05:53 PM
Woodworth Emily	SVP, Global Controller and CAO	Feb 17 '25	Option Exercise	0.00	667	0	4,584	Feb 18 05:53 PM
Sorenson John Bradley	EVP, Global Operations	Feb 14 '25	Option Exercise	0.00	2,115	0	27,609	Feb 18 05:52 PM
Sorenson John Bradley	EVP, Global Operations	Feb 17 '25	Option Exercise	0.00	1,500	0	27,635	Feb 18 05:52 PM
Sorenson John Bradley	EVP, Global Operations	Feb 16 '25	Option Exercise	0.00	1,273	0	26,716	Feb 18 05:52 PM
Sorenson John Bradley	EVP, Global Operations	Feb 14 '25	Sale	106.31	1,201	127,678	25,443	Feb 18 05:52 PM
O'Sullivan Miriam	SVP, Chief HR Officer	Feb 14 '25	Option Exercise	0.00	106	0	1,650	Feb 18 05:52 PM
O'Sullivan Miriam	SVP, Chief HR Officer	Feb 14 '25	Option Exercise	0.00	1,123	0	13,702	Feb 18 05:52 PM
O'Sullivan Miriam	SVP, Chief HR Officer	Feb 16 '25	Option Exercise	0.00	990	0	14,362	Feb 18 05:52 PM
O'Sullivan Miriam	SVP, Chief HR Officer	Feb 16 '25	Option Exercise	0.00	85	0	1,697	Feb 18 05:52 PM
O'Sullivan Miriam	SVP, Chief HR Officer	Feb 17 '25	Option Exercise	0.00	1,000	0	15,071	Feb 18 05:52 PM
O'Sullivan Miriam	SVP, Chief HR Officer	Feb 17 '25	Option Exercise	0.00	100	0	1,767	Feb 18 05:52 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 14 '25	Option Exercise	0.00	2,776	0	32,477	Feb 18 05:52 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 16 '25	Option Exercise	0.00	2,970	0	34,181	Feb 18 05:52 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 17 '25	Option Exercise	0.00	3,334	0	36,160	Feb 18 05:52 PM
Mahoney Michael F	Chairman, President & CEO	Feb 14 '25	Option Exercise	0.00	16,524	0	1,643,475	Feb 18 05:52 PM
Mahoney Michael F	Chairman, President & CEO	Feb 16 '25	Option Exercise	0.00	16,265	0	1,651,750	Feb 18 05:52 PM
Mahoney Michael F	Chairman, President & CEO	Feb 17 '25	Option Exercise	0.00	18,334	0	1,662,219	Feb 18 05:52 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Feb 14 '25	Option Exercise	0.00	4,362	0	179,108	Feb 18 05:52 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Feb 16 '25	Option Exercise	0.00	3,960	0	181,078	Feb 18 05:52 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Feb 17 '25	Option Exercise	0.00	4,167	0	183,439	Feb 18 05:52 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Feb 17 '25	Option Exercise	0.00	2,834	0	23,550	Feb 18 05:50 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Feb 16 '25	Option Exercise	0.00	2,546	0	21,947	Feb 18 05:50 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Feb 14 '25	Option Exercise	0.00	3,172	0	20,935	Feb 18 05:50 PM
Brown Vance R	SVP, GC and Corp. Secretary	Feb 17 '25	Option Exercise	0.00	1,000	0	51,155	Feb 18 05:50 PM
Brown Vance R	SVP, GC and Corp. Secretary	Feb 16 '25	Option Exercise	0.00	1,839	0	51,045	Feb 18 05:50 PM
Brown Vance R	SVP, GC and Corp. Secretary	Feb 14 '25	Option Exercise	0.00	1,850	0	50,101	Feb 18 05:50 PM
Brennan Daniel J.	EVP and CFO	Feb 17 '25	Option Exercise	0.00	4,584	0	252,365	Feb 18 05:50 PM
Brennan Daniel J.	EVP and CFO	Feb 16 '25	Option Exercise	0.00	4,243	0	249,833	Feb 18 05:50 PM
Brennan Daniel J.	EVP and CFO	Feb 14 '25	Option Exercise	0.00	4,362	0	247,700	Feb 18 05:50 PM
JOHN B SORENSON	Officer	Feb 18 '25	Proposed Sale	104.41	2,657	277,417		Feb 18 04:09 PM
DANIEL BRENNAN	Officer	Feb 18 '25	Proposed Sale	104.57	17,530	1,833,184		Feb 18 04:09 PM
Carruthers Wendy	Officer	Feb 14 '25	Proposed Sale	106.45	9,393	999,911		Feb 14 05:32 PM
Woodworth Emily	SVP, Global Controller and CAO	Feb 12 '25	Option Exercise	0.00	480	0	3,437	Feb 14 05:30 PM
Sorenson John Bradley	EVP, Global Operations	Feb 12 '25	Option Exercise	0.00	1,731	0	26,024	Feb 14 05:30 PM
O'Sullivan Miriam	SVP, Chief HR Officer	Feb 12 '25	Option Exercise	0.00	65	0	1,567	Feb 14 05:30 PM
O'Sullivan Miriam	SVP, Chief HR Officer	Feb 12 '25	Option Exercise	0.00	961	0	12,917	Feb 14 05:30 PM
Mahoney Michael F	Chairman, President & CEO	Feb 12 '25	Option Exercise	0.00	13,704	0	1,633,577	Feb 14 05:29 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 12 '25	Option Exercise	0.00	2,115	0	30,569	Feb 14 05:29 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Feb 12 '25	Option Exercise	0.00	3,462	0	176,325	Feb 14 05:29 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Feb 12 '25	Option Exercise	0.00	2,692	0	18,713	Feb 14 05:29 PM
Brown Vance R	SVP, GC and Corp. Secretary	Feb 12 '25	Option Exercise	0.00	1,442	0	48,675	Feb 14 05:28 PM
Brennan Daniel J.	EVP and CFO	Feb 12 '25	Option Exercise	0.00	3,654	0	245,105	Feb 14 05:28 PM
JOHN B SORENSON	Officer	Feb 14 '25	Proposed Sale	106.31	1,201	127,678		Feb 14 04:02 PM
Sorenson John Bradley	EVP, Global Operations	Feb 12 '25	Sale	105.06	6,389	671,249	24,293	Feb 13 04:32 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 12 '25	Sale	105.06	13,022	1,368,073	28,454	Feb 13 04:32 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Dec 03 '24	Buy	90.29	50	4,515	148,168	Feb 13 04:32 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Dec 10 '24	Sale	89.97	20	1,799	148,148	Feb 13 04:32 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

BSX

Boston Scientific Corp

Upgrade your FINVIZ experience